Michael del Aguila PhD is Senior Vice President of Client Solutions. Dr. del Aguila is an executive with over 20 years’ experience in health services research with positions in commercial biopharma organizations and managed care. He has led organizations providing cross portfolio support in health economics and outcomes research, and Phase 3b/4 clinical research at Roche/Genentech, and more recently.  He led cross-functional teams of biostatisticians, data management, and HEOR scientists to develop and conduct research programs to support launch and medical market access activities in oncology, immunology, cardiovascular, transplant and virology. This included design, conduct and analysis of 20 clinical studies, including trials and registries, as well as other observational studies.

As Senior Director in global Pricing and Market Access at Gilead, Michael led a team of market access and pricing specialists to support the global launches of Sovaldi and Stribild and Zydelig.  Previously, as Director in global strategic pricing and reimbursement at Schering Plough, Michael was responsible for coordinating submission of dossiers to NICE for Temodar, Vytorin and Remicade.